+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Visudyne"

Macular Degeneration Pipeline Analysis Report - Product Thumbnail Image

Macular Degeneration Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Visudyne is a drug used to treat optical disorders, such as age-related macular degeneration (AMD). It is a photodynamic therapy (PDT) drug, which works by delivering a light-activated drug to the eye to destroy abnormal blood vessels that cause vision loss. Visudyne is administered through an intravenous injection, and the light is then delivered to the eye through a special contact lens. Visudyne is the only PDT drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of AMD. The Visudyne market is composed of pharmaceutical companies that manufacture and distribute the drug, as well as medical professionals who administer the treatment. Visudyne is used in many countries around the world, and is a popular treatment option for AMD. Some companies in the Visudyne market include Novartis, Bausch + Lomb, and QLT Inc. Show Less Read more